Bulkamid: one year anniversary of FDA approval in the United States Posted on 3 February 2021 | by Frederik Steen Jensen | Leave a Comment on Bulkamid: one year anniversary of FDA approval in the United States
Completion of prospective open label clinical study of Arthrosamid® for knee osteoarthritis Posted on 25 January 2021 | by Frederik Steen Jensen | Leave a Comment on Completion of prospective open label clinical study of Arthrosamid® for knee osteoarthritis
Completion of recruitment for a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis. Posted on 25 January 2021 | by Frederik Steen Jensen | Leave a Comment on Completion of recruitment for a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis.
Approval of Arthrosamid® for the treatment of knee osteoarthritis Posted on 25 January 2021 | by Frederik Steen Jensen | Leave a Comment on Approval of Arthrosamid® for the treatment of knee osteoarthritis
Contura expands its commercial efforts to the US and appoints new US Leadership Team Posted on 10 February 2020 | by Frederik Steen Jensen | Leave a Comment on Contura expands its commercial efforts to the US and appoints new US Leadership Team
FDA approves Bulkamid® in the United States and is now set for launch in Quarter 1 2020 Posted on 1 January 2020 | by Frederik Steen Jensen | Leave a Comment on FDA approves Bulkamid® in the United States and is now set for launch in Quarter 1 2020
Results of Randomised Controlled Trial of Bulkamid® versus Tension-free Vaginal Tape Published Posted on 1 January 2020 | by Frederik Steen Jensen | Leave a Comment on Results of Randomised Controlled Trial of Bulkamid® versus Tension-free Vaginal Tape Published
Urethral bulking agents to be considered as two distinct classes: particulate and non-particulate Posted on 1 December 2019 | by Frederik Steen Jensen | Leave a Comment on Urethral bulking agents to be considered as two distinct classes: particulate and non-particulate
Observational multicentered study shows that two thirds of women with stress urinary incontinence choose Bulkamid® when offered a choice Posted on 1 December 2019 | by Frederik Steen Jensen | Leave a Comment on Observational multicentered study shows that two thirds of women with stress urinary incontinence choose Bulkamid® when offered a choice
Completion of recruitment to a prospective, open-label clinical investigation of Arthrosamid for knee osteoarthritis Posted on 17 October 2019 | by Frederik Steen Jensen | Leave a Comment on Completion of recruitment to a prospective, open-label clinical investigation of Arthrosamid for knee osteoarthritis
